Bioventus: DUROLANE Update in Australia, New Zealand

In Australia and New Zealand, Bioventus received expanded indications for DUROLANE (3mL) and is launching DUROLANE SJ (1mL) osteoarthritis treatment. The hyaluronic acid-based products will be available through distribution partner LMT Surgical within 2019.

DUROLANE SJ is indicated to treat mild to moderate OA pain in the ankle, elbow, wrist,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us